Updated: 2 hours 56 min ago
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
As monkeypox cases rise, the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) have today published a technical report to provide advice for health authorities and event organisers for the upcoming summer.
Implications of the emergence and spread of the SARS-CoV-2 variants of concern BA.4 and BA.5 for the EU/EEA
Most EU/EEA countries have detected low proportions of the SARS-CoV-2 variants BA.4 and BA.5, however many have seen an increase in recent weeks.
This report provides an overview of the cases of hepatitis of unknown origin in children reported to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy).
Since the last update on 31 May 2022, 384 monkeypox cases have been reported from 16 EU/EEA countries and 238 monkeypox cases have been reported from 8 non-EU/EEA countries.
New SARS-CoV-2 variants of interest and concern have continued to emerge in the first few months of 2022 and monitoring their circulation in all countries through genomic surveillance remains important.
As of 3 June 2022, 392 confirmed (n=370) and probable (n=22) cases of monophasic S. Typhimurium have been identified in the EU/EEA and the United Kingdom.
This report presents an update of monkeypox confirmed cases in the European Union/European Economic Area (EU/EEA) and worldwide.
A new online modelling hub launched today, the European COVID-19 Scenario Hub, will present modelling projections on how the COVID-19 pandemic may evolve in terms of cases, hospitalisations and deaths.
A multi-country outbreak of monkeypox is ongoing since early May. As of 25 May 2022, a total of 219 confirmed cases have been reported worldwide, with most of cases being detected in young men, self-identifying as men who have sex with men (MSM).
ECDC has published a technical report which contains the results of a review and update of the core competencies in applied infectious disease epidemiology for mid-career applied epidemiologists.
In a Rapid Risk Assessment published today, the European Centre for Disease Prevention and Control (ECDC) recommends EU/EEA countries focus on prompt identification, management, contact tracing and reporting of new monkeypox cases.
From 16 to 18 May, ECDC hosted a hybrid meeting for the National Focal Points and alumni fellows from the Mediterranean and Black Sea Programme for Intervention Epidemiology Training network (MediPIET) to discuss how to further improve the MediPIET structure and training activities.
As of 16 May 2022, there is a multi-country outbreak of monkeypox affecting the UK, EU/EEA states, and North America. As of 20 May 2022, there have been a total of 36 confirmed cases reported worldwide.
Since the last epidemiological update published on 11 May 2022, new cases of hepatitis of unknown aetiology among children aged 16 years and under have been reported worldwide.
Several cases of monkeypox have been confirmed in Europe, including an EU Member State (Portugal).
Rapid outbreak assessment – first update: Multi-country Salmonella outbreak linked to chocolate products
On 18 May 2022, ECDC and EFSA published an update of the rapid outbreak assessment on a multi-country outbreak of monophasic Salmonella Typhimurium linked to chocolate products made at a factory in Arlon, Belgium.
As of 12 May 2022, ECDC has reclassified Omicron sub-lineages BA.4 and BA.5 from variants of interest to variants of concern.
ECDC and the WHO Regional Office for Europe are publishing a joint surveillance bulletin on the current outbreak of hepatitis of unknown origin in children.
Since the first alert launched by the United Kingdom (UK) on 5 April 2022, probable cases of hepatitis of unknown aetiology in children have been reported from several countries worldwide.